Menlo Park, CA, August 1, 2022 – FlemingMartin is pleased to announce that Personalis (NASDAQ: PSNL), a company transforming the development of next-generation therapies by providing comprehensive molecular data on each patient’s cancer and immune response, has hired Sherry Kan as Vice President of Marketing and Product Management. In driving a best-in-class team, Sherry will develop, shape, and execute the marketing of all current and future products for Personalis, propelling the Company to new heights in the molecular diagnostics marketplace. Sherry brings significant marketing, product management, and corporate strategy expertise to Personalis from her tenures with Exact Sciences (NASDAQ: EXAS), Becton Dickinson (NYSE: BDX), Alexion Pharmaceuticals (formerly, NASDAQ: ALXN), and McKinsey & Co. Most recently, Sherry guided commercial management of the precision oncology business’s therapy selection NGS portfolio at Exact. In this position, she directed a team of 16 leaders spanning product lifecycle management, HCP marketing, marketing communications, and program management. Sherry earned her B.S. in Biology from the Massachusetts Institute of Technology, and she received her Ph.D. in Molecular Biology and Microbiology from The Rockefeller University.
